Lipidome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys with Metabolic Dysfunction-Associated Steatotic Liver Disease

Helaina E. Huneault,Chih-Yu Chen,Catherine C. Cohen,Xueyun Liu,Zachery R. Jarrell,Zhulin He,Karla E. DeSantos,Jean A. Welsh,Kristal M. Maner-Smith,Eric A. Ortlund,Jeffrey B. Schwimmer,Miriam B. Vos

DOI: https://doi.org/10.3390/metabo14040191

IF: 4.1

2024-03-29

Metabolites

Abstract:Little is known about lipid changes that occur in the setting of metabolic-dysfunction-associated steatotic liver disease (MASLD) regression. We previously reported improvements in hepatic steatosis, de novo lipogenesis (DNL), and metabolomic profiles associated with oxidative stress, inflammation, and selected lipid metabolism in 40 adolescent boys (11–16 y) with hepatic steatosis ≥5% (98% meeting the definition of MASLD). Participants were randomized to a low-free-sugar diet (LFSD) (n = 20) or usual diet (n = 20) for 8 weeks. Here, we employed untargeted/targeted lipidomics to examine lipid adaptations associated with the LFSD and improvement of hepatic steatosis. Our LC-MS/MS analysis revealed decreased triglycerides (TGs), diacylglycerols (DGs), cholesteryl esters (ChE), lysophosphatidylcholine (LPC), and phosphatidylcholine (PC) species with the diet intervention (p < 0.05). Network analysis demonstrated significantly lower levels of palmitate-enriched TG species post-intervention, mirroring the previously shown reduction in DNL in response to the LFSD. Targeted oxylipins analysis revealed a decrease in the abundance of 8-isoprostane and 14,15-DiHET and an increase in 8,9-DiHET (p < 0.05). Overall, we observed reductions in TGs, DGs, ChE, PC, and LPC species among participants in the LFSD group. These same lipids have been associated with MASLD progression; therefore, our findings may indicate normalization of key biological processes, including lipid metabolism, insulin resistance, and lipotoxicity. Additionally, our targeted oxylipins assay revealed novel changes in eicosanoids, suggesting improvements in oxidative stress. Future studies are needed to elucidate the mechanisms of these findings and prospects of these lipids as biomarkers of MASLD regression.

biochemistry & molecular biology

What problem does this paper attempt to address?

This paper aims to explore the effect of dietary intervention on the changes in the lipidome of adolescent male patients with metabolic - dysfunction - associated fatty liver disease (MASLD). Specifically, through non - targeted and targeted lipidomics analysis, the study examined the changes in the lipid profile related to MASLD after 8 weeks of low - free - sugar diet (LFSD) intervention. The main objective of the study was to understand how changes in lipid metabolism are associated with liver fat reduction and to explore whether these changes can serve as biomarkers for MASLD remission.

The research background indicates that MASLD is the most common liver disease in children, characterized by excessive fat accumulation in the liver and accompanied by at least one of five cardiometabolic risk factors. A high - sugar diet is considered an important factor contributing to MASLD because it increases lipid accumulation in the liver. Previous studies have shown that a diet restricting free - sugar intake can significantly reduce liver fat content and de novo lipogenesis (DNL). However, there are relatively few current studies on the specific changes in the lipidome during MASLD remission. Therefore, this study hopes to provide new insights into the pathophysiological process of MASLD through in - depth analysis of lipidome changes.